Co-Zn single atoms anchored carbon nanotubes derived from anti-perovskite carbides for boosted hydrogen evolution and oxygen reduction reactions
Chemical Engineering Journal · 2024-09 · 496 · 154255
DOI: 10.1016/j.cej.2024.154255 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Engineering Journal, 2024-09. Verfasst von Liangliang Feng und 11 weiteren Autor:innen. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: Natural Science Foundation of Shaanxi Province, National Natural Science Foundation of China, Key Research and Development Projects of Shaanxi Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Natural Science Foundation of Shaanxi Province
- National Natural Science Foundation of China
- Key Research and Development Projects of Shaanxi Province
- Shaanxi University of Science and Technology
Zitieren
APA
Feng, L., Zhou, M., He, D., Yin, H., Huang, Y., Cao, L., Fang, Y., Chu, D., Liu, Y., Chen, H., Li, G., & Huang, J. (2024). Co-Zn single atoms anchored carbon nanotubes derived from anti-perovskite carbides for boosted hydrogen evolution and oxygen reduction reactions. Chemical Engineering Journal, 496, 154255. https://doi.org/10.1016/j.cej.2024.154255
Vancouver
Feng L, Zhou M, He D, Yin H, Huang Y, Cao L, et al. Co-Zn single atoms anchored carbon nanotubes derived from anti-perovskite carbides for boosted hydrogen evolution and oxygen reduction reactions. Chemical Engineering Journal. 2024;496:154255. doi:10.1016/j.cej.2024.154255
BibTeX
@article{Feng2024,
author = {Feng, Liangliang and Zhou, Mengfei and He, Danyang and Yin, Hongyan and Huang, Yixuan and Cao, Liyun and Fang, Yuan and Chu, Dewei and Liu, Yipu and Chen, Hui and Li, Guodong and Huang, Jianfeng},
title = {Co-Zn single atoms anchored carbon nanotubes derived from anti-perovskite carbides for boosted hydrogen evolution and oxygen reduction reactions},
journal = {Chemical Engineering Journal},
year = {2024},
volume = {496},
pages = {154255},
doi = {10.1016/j.cej.2024.154255}
}
EUVIMED